MedPath

Parathyroid Auto-transplantation: Prospective Randomized Trial of the Personalized Site

Not Applicable
Conditions
Parathyroid Autologous Transplantation
Registration Number
NCT02906748
Lead Sponsor
Tongji Hospital
Brief Summary

The functional parathyroid auto-transplantation (PA) could release parathyroid hormone (PTH) into the circulatory system of the body through the capillaries. But when parathyroid glands were auto-grafted in the sternocleidomastoid muscle, it would be inconvenient to detect PTH to examine whether the graft functions. So the investigators took the forearm as the aim place for auto-transplantation, either subcutaneous or brachioradialis, with its relatively fixed - antecubital vein blood test which is simple. The survival criteria is assumed as the PTH gradient of 1.5 times or greater through comparing the bilateral PTH value in grafted and not-grafted forearm.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
280
Inclusion Criteria
  • patients with indications for PA treatment during cervical surgery
Exclusion Criteria
  • patients suffering secondary hypoparathyroidism with forearm fistulization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
parahthyroid hormone gradient by comparing between grafted and non-grafted forearm1 months, 3 months and 6 months

The survival criteria is that the gradient of parathyroid hormone reaches 1.5 time or greater by comparing between grafted and non-grafted forearm

Secondary Outcome Measures
NameTimeMethod
hypoparathyroidism: parathyroid hormone less than 15pg/ml(range from 15 to 65pg/ml)6 months

Trial Locations

Locations (1)

Tongji Hospital

🇨🇳

Wuhan, Hubei, China

Tongji Hospital
🇨🇳Wuhan, Hubei, China
Gaosong Wu, PhD
Contact
0086-138-7144-4606
wugaosongtj@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.